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Introduction
Anxiety is a physiological, protective response to real or
potential threats. Excessive anxiety is a feature of sever-
al affective disorders and has a lifetime prevalence as
high as 25% in the United States (1). Current evidence
indicates that genetic factors regulate anxiety. Human
studies have detected associations between panic disor-
der and polymorphisms in genes for MAO-A (2), the
adenosine A2a receptor (3), and cholecystokinin (4, 5).
Physiological anxiety appears to be a polygenic trait, and
recent analysis of high- and low-activity strains of mice
has identified quantitative trait loci on chromosomes 1,
4, 7, 12, 14, 15, 18, and X that influence anxiety-like
behaviors (6). Moreover, several single gene mutations
alter anxiety-like behavior in mice, including null muta-
tions in the corticotropin-releasing factor (CRF) recep-
tor-1 (7, 8), the glucocorticoid receptor (9), the α sub-
unit of calcium/calmodulin–dependent protein kinase
II (10), and protein kinase Cγ (PKCγ) (11), which all
reduce anxiety-related behaviors. In contrast, null muta-
tions in glutamate decarboxylase (GAD) 65 (12), which
synthesizes gamma aminobutyrate (GABA), the GABA
type A (GABAA) receptor γ2 subunit (13), CRF receptor-
2 (14, 15), and the serotonin 5-HT1A receptor (16–18)
increase anxiety-like behavior in mice.
Most drugs used to treat anxiety act at GABAA or
serotonin receptors (19). Using PKCε-null mice, we
found evidence indicating that PKCε regulates the
function of GABAA receptors. These mice are similar in
length and weight to wild-type littermates, behave nor-
mally in their home cage, and show no compensatory
changes in the abundance of other PKC isozymes in the
nervous system (20, 21). They show reduced ethanol
preference and operant self-administration of ethanol
(20, 22) in association with heightened sensitivity to
the locomotor-activating effects of ethanol and
diazepam and to the hypnotic actions of pentobarbital,
ethanol, and diazepam, which are positive allosteric
modulators of GABAA receptors (20). This is associat-
ed with increased sensitivity to the actions of ethanol
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and flunitrazepam on GABAA receptor function in
vitro. Since drugs that activate GABAA receptors reduce
anxiety, we predicted that PKCε-null mice would show
reduced anxiety-like behaviors. Here we report that
absence of PKCε reduces anxiety-like behaviors and
stress responses by enhancing GABAA receptor func-
tion in the CNS. This involves, in part, heightened sen-
sitivity to the positive allosteric action of endogenous
neurosteroids at GABAA receptors.
Methods
Materials. (+)-Bicuculline (Sigma-Aldrich, St. Louis,
Missouri, USA) was dissolved in 50 µl of glacial acetic
acid, diluted in saline to pH 3.0, and administered to
mice at 10 ml/kg body weight. Vehicle-treated mice
received an equal volume of acidified saline. Alphax-
alone was purchased from ICN Biomedicals Inc.
(Aurora, Ohio, USA), and allopregnanolone, preg-
nanolone, CRF, and metyrapone were from Sigma-
Aldrich. Alphaxaolone, allopregnanolone, preg-
nanolone, and metyrapone were prepared as 10-mM
stock solutions in DMSO. All drugs were administered
by intraperitoneal injection.
Animal care. PKCε-null mice were derived by homolo-
gous recombination in J1 embryonic stem cells (21). F1
generation hybrid C57Bl/6J × 129SvJae heterozygous
progeny were intercrossed to generate F2 generation
hybrid wild-type and PKCε-null littermates for study. In
early work, some studies were performed using F3 and
F4 generation hybrid mice, produced by intercrossing
C57Bl/6J × 129SvJae heterozygous mice from the previ-
ous generation. The results obtained were similar to
those obtained with F2 hybrid mice and therefore were
pooled with F2 hybrid data. Chimeras were also crossed
with 129SvJae mice to generate inbred 129SvJae wild-
type and PKCε-null littermates for some experiments.
For behavioral and stress hormone studies, 10- to 12-
week-old mice were maintained under a 12-hour
light/dark cycle (lights on at 6 a.m.) and were individu-
ally housed for 4 days prior to study. Behaviors were
examined during the light phase between 10 a.m. and 1
p.m. For in vitro studies of GABAA receptor function, we
used group-housed male and female mice. Unless oth-
erwise designated, we used mice of both genders for
studies. The experimental mice were fed standard lab
chow ad libitum. The Institutional Animal Care and
Use Committees of the University of California, San
Francisco and the Ernest Gallo Clinic and Research
Center approved all experimental procedures.
Open-field testing. Spontaneous locomotor activity was
measured in brightly lit (500 lux) chambers (43 × 43 cm)
as described (21). For assessment of activity in the cen-
ter of the field, the chamber floor was divided post hoc
into a center zone (21 × 21 cm; center equidistant from
all four walls of the chamber) and a periphery zone (the
remaining area of the floor). Distance traveled and time
spent in each area was calculated from the locomotor
activity data. After each test session, the equipment was
cleaned with 70% ethanol to remove animal odors.
Elevated plus maze. Mice were examined in a quiet
room under normal fluorescent room light (500 lux).
Two different mazes were used. The first, used in Fig-
ure 2, was elevated 60 cm off the floor, constructed of
wood coated with gloss enamel white paint, and had
two open arms (37L × 8W cm) and two closed arms
(37L × 8W × 14H cm) extending from a common cen-
tral platform (8 cm × 8 cm). White tape was placed on
the floor to provide traction. An observer blind to the
genotype of the mouse placed it on the central plat-
form and allowed it to wander for 10 minutes. The
observer remained in the room during the test. The x
and y coordinates of the center of the mouse were con-
tinuously monitored (30 Hz) in the maze using a video-
tracking system (Videomex-V; Columbus Instruments,
Columbus, Ohio, USA). Following each session, the
maze was cleaned with 70% ethanol to remove odors.
Studies described in Figure 6 were performed using this
maze and another maze constructed of Plexiglas
(Hamilton-Kinder LLC, Poway, California, USA). This
second maze consisted of two open arms (38L × 5W
cm) and two closed arms (38L × 5W × 15H cm), with a
central intersection (5 cm × 5 cm) elevated 75 cm above
the floor. A Plexiglas rim framed the edges of the open
arms. Movement was detected by rows of 48 infrared
photobeams interfaced with a computer. An observer
blind to the genotype of the mouse placed it on the cen-
tral platform and allowed it to wander in the maze for
10 minutes. The observer was not present in the room
during this time. Results from both mazes were similar
and were combined for analysis.
36Cl uptake assay. Muscimol-stimulated 36Cl uptake
was measured in cortical microsacs as described (20).
Neurosteroids were present during the 5-second incu-
bation with muscimol and 36Cl.
Hormone measurements. Studies were performed be-
tween 9 and 11 a.m. Brain allopregnanolone concentra-
tions were measured in mice anesthetized with CO2 and
then decapitated. The brain was rapidly removed, and
the forebrain was dissected free, frozen in liquid nitro-
gen, and stored at –70°C. The concentration of allo-
pregnanolone in the forebrain was measured by RIA
(23). Plasma corticosterone and adrenocorticotrophic
hormone (ACTH) were measured before and after
restraint stress. For basal levels, mice were anesthetized
with CO2 and then rapidly decapitated. Blood was col-
lected from the trunk. For studies of restraint stress,
mice were placed in a plastic restrainer consisting of a
smooth tube with a fenestrated stopper at the end. The
tube limited the animal’s ability to move about, but
there was enough space for the mouse to turn around.
After being restrained for 10 minutes, mice were anes-
thetized with CO2 and decapitated for collection of
trunk blood either immediately after removal from the
restrainer or 1 hour later. Hormone-stimulation tests
were performed on mice individually housed for 3 days
before intraperitoneal injection of either CRF (10
µg/kg), metyrapone (100 mg/kg), or an equivalent vol-
ume of saline. Thirty minutes after injection, mice were
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anesthetized with CO2 and decapitated to collect trunk
blood for analysis. Plasma corticosterone and ACTH
were measured using 125I RIA kits from ICN Biomed-
icals Inc. (Costa Mesa, California, USA).
Immunohistochemistry. An affinity-purified anti-PKCε
polyclonal antibody SN134 was generated in rabbits
(SynPep Corp., Dublin, California, USA) against the 
C-terminal mouse PKCε peptide NQEEFKGFSYF-
GEDLMP (24). Mice were perfused with PBS, followed
by 4% paraformaldehyde (PFA) in 0.1 M phosphate
buffer, pH 7.4. Brains were removed and postfixed
overnight in 4% PFA, equilibrated for 48 hours in 30%
sucrose in PBS at 4°C, embedded in OCT (Sakura
Finetek, Torrance, California, USA), and frozen in liq-
uid nitrogen. PKCε immunoreactivity was identified
in 10-µm frozen sections using SN134 (0.4 µg/ml) fol-
lowed by detection with biotinylated anti-rabbit 
IgG and avidin-peroxidase (Vector Laboratories,
Burlingame, California, USA).
Loss of the righting reflex. Mice were given an intraperi-
toneal injection of pregnanolone (32 mg/kg) and placed
on their backs. The time interval between loss and return
of the righting reflex was then recorded. Animals were
judged to have regained the reflex when they could right
themselves three times within a 30-second interval.
Results
Reduced anxiety-like behaviors in PKC-null mice. Since mice
have a natural aversion to the brightly lit center of an
open field, comparison of activity in the center versus
the periphery of the field gives an indication of anxiety-
related behavior (25). Since three-factor ANOVA
revealed no significant difference in activity as a func-
tion of gender or a gender by genotype interaction, we
combined data from male and female mice. Activity did
not vary by genotype in the periphery or total areas of
the field (Figure 1, b and c). However, PKCε-null mice
traveled more in the center than wild-type mice on days
1 and 2 (Figure 1a). Moreover, the percentages of total
distance traveled and total time spent in the center
were significantly greater in PKCε-null mice compared
with wild-type littermates (Figure 1, d and e).
We next performed an elevated plus maze test,
which exploits the conflict between exploration of a
novel area and aversion to open areas and height. We
used inbred 129SvJae mice in addition to hybrid
C57BL/6J × 129SvJae mice to determine if decreases
in anxiety-like behavior could be observed on a differ-
ent genetic background. Hybrid PKCε-null mice spent
a greater percentage of time in the open arms and
showed a greater percentage of entries into the open
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Figure 1
Open-field activity. Data are mean ± SEM values from 19 wild-type
and 20 PKCε-null hybrid mice. (a) Locomotor activity in the center
varied as a function of genotype (F1,38 = 5.1, P < 0.05) and test day
(F2,64 = 26, P < 0.001) (two-way repeated measures ANOVA). 
*P < 0.05 compared with wild-type mice on the same day (Tukey’s
test). Activity also varied by test day in the periphery (b) (F2,64 = 37.2,
P < 0.001) and total field (c) (F2,64 = 38.6, P < 0.001), but not by
genotype in these areas. Activity on days 2 and 3 was different from
that on day 1 regardless of genotype or area (Tukey’s test, P < 0.05).
(d) The percentage of total distance traveled in the center varied by
genotype (F1,38 = 5.7, P = 0.022) and test day (F2,64 = 12.7, 
P < 0.001) and was less on days 2 and 3 compared with day 1
(Tukey’s test, P < 0.05). (e) The percentage of time spent in the cen-
ter varied by genotype (F1,38 = 8.1, P = 0.007) and test day 
(F2,64 = 5.8, P = 0.005), and was less on day 3 compared with day 1
(Tukey’s test P < 0.05). *P < 0.05 compared with wild-type mice on
the same day (Tukey’s test).
Figure 2
Elevated plus maze test. The percentage of entries into the open arms
and the percentage of time spent on the open arms was greater in
hybrid (a) and 129SvJae (b) PKCε-null male mice compared with
wild-type male littermates. The number of entries into the closed
arms was similar in both genotypes regardless of genetic background.
Data are mean ± SEM values from 12 hybrid wild-type and 12 hybrid
PKCε-null male mice, and 8 wild-type 129SvJae and 7 PKCε-null
129SvJae male mice (two-tailed t tests).
arms compared with wild-type littermates (Figure 2a).
There was no difference in the number of entries into
the closed arms, confirming that overall locomotor
activity was similar in both genotypes. Similar geno-
type-specific differences in open-arm entries and time
spent in the open arms were apparent in inbred
129SvJae mice (Figure 2b).
Reduced stress responses in PKCε-null mice. Since our
findings indicated reduced anxiety-like behavior in
PKCε-null mice, we postulated that these mice would
also show a reduced response to stress. To assess the
intensity of response to stressors, we measured plasma
levels of the stress hormones corticosterone and ACTH.
Baseline levels of these hormones were lower in PKCε-
null mice compared with wild-type mice (Figure 3, a
and b). Immediately after a 10-minute period of
restraint, corticosterone levels increased in both geno-
types, but were still lower in PKCε-null mice (Figure
3a). One hour after restraint, levels remained elevated
in wild-type mice, whereas in PKCε-null mice they were
no longer significantly different than baseline.
Decreased levels of stress hormones could result from
reduced pituitary response to the hypothalamic hor-
mones arginine vasopressin (AVP) and CRF, which
stimulate secretion of ACTH, or from a reduced adre-
nal response to ACTH. However, CRF evoked similar
levels of ACTH and corticosterone in both genotypes
(Figure 3, c and d). In addition, adrenal weight was sim-
ilar (P = 0.43) in wild-type (6.06 ± 0.57 mg; n = 15) and
PKCε-null (6.15 ± 0.63 mg; n = 12) mice. Since
decreased basal levels of corticosterone and ACTH
could result from impaired release of CRF and AVP
from the paraventricular nucleus of the hypothalamus
(PVN), we examined the capacity of the PVN to drive
the HPA axis by blocking glucocorticoid-mediated
feedback suppression of the PVN with metyrapone,
which inhibits adrenal corticosterone synthesis.
Metyrapone reduced levels of corticosterone (Figure 3c)
and evoked similar elevations in ACTH in PKCε-null
and wild-type mice (Figure 3d).
PKCε-null mice show increased sensitivity to neurosteroids.
GABAA receptors from PKCε-null mice show enhanced
sensitivity to the allosteric activators ethanol and flu-
nitrazepam (20). If reduced anxiety-like behavior in
PKCε-null mice is related to increased sensitivity of
GABAA receptors to allosteric activators, then there
must be an endogenous activator that is more effective
in PKCε-null mice. One candidate is the neurosteroid
allopregnanolone, a metabolite of progesterone that
allosterically enhances the action of GABA at GABAA
receptors (26). Treatment of membranes (microsacs)
isolated from frontal cortex of mice with allopreg-
nanolone or the related compound pregnanolone
enhanced muscimol-stimulated 36Cl uptake in both
wild-type and PKCε-null mice, but the effect was
greater in PKCε-null mice (Figure 4a). Examination of
the concentration-response relationship using a syn-
thetic analogue, alphaxalone, revealed that absence of
PKCε was associated with an increase in the maximal
effect rather than a change in the ED50 for the neuros-
teroid (Figure 4a). These in vitro results were associat-
ed with enhanced sensitivity to the hypnotic effect of
pregnanolone as assessed by the duration of the loss of
righting reflex (Figure 4c). They were not associated
with a difference in brain allopregnanolone concentra-
tion in PKCε-null mice (Figure 4d).
Bicuculline restores wild-type levels of corticosterone and
anxiety-like behavior in PKCε-null mice. The HPA axis is
regulated by limbic forebrain circuits that stimulate or
inhibit release of CRF and AVP from the PVN (27).
Inhibitory circuits connect with the PVN through
GABA-containing neurons in the bed nucleus of the
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Figure 3
Stress hormone responses. (a) Mean ± SEM corticosterone levels in
hybrid male mice before restraint (basal; n = 23 wild-type, 22 PKCε-
null), after 10 minutes of restraint (n = 11 of each genotype), or 1
hour after restraint (n = 6 of each genotype). Two-factor ANOVA
showed significant effects of genotype (F1,73 = 24.03; P < 0.001) and
treatment (F2,73 = 33.44; P < 0.001). *P < 0.05 compared with wild-
type levels for each treatment and †P < 0.05 compared with basal lev-
els in same genotype (Tukey’s test). (b) Basal ACTH levels were ele-
vated in hybrid male wild-type mice (n = 16) compared with
PKCε-null (n = 13) mice (P = 0.012, two-tailed t test). (c) Corticos-
terone levels in hybrid male mice 30 minutes after intraperitoneal
injection (500 µl) of saline, 10 µg/kg CRF, or 100 mg/kg
metyrapone. Two-factor ANOVA showed a significant effect of treat-
ment (F2,76 = 18.5, P < 0.001) but not genotype, with levels higher
after CRF and lower after metyrapone than after saline (P < 0.001,
Newman Keuls test). *P = 0.026 compared with saline-treated wild-
type mice (Newman Keuls test). (d) ACTH levels in hybrid male mice
30 minutes after treatment with saline, CRF, or metyrapone. Two-
factor ANOVA revealed an effect of treatment (F2,62 = 9.81, 
P < 0.001) but not of genotype with ACTH levels higher after CRF or
metyrapone than after saline (P < 0.05, Newman Keuls test).
stria terminalis, the preoptic area, and the hypothala-
mus. Stimulation of these neurons inhibits the HPA
axis, presumably through activation of GABAA recep-
tors present on PVN neurons. Since in previous work
we found that GABAA receptor responses are enhanced
in PKCε-null mice (20), we postulated that the lower
levels of corticosterone present following stress in these
mice were related to increased GABA-mediated sup-
pression of the HPA axis. To investigate this possibili-
ty, we induced stress by injecting mice with saline alone
or with saline containing the GABAA receptor antago-
nist bicuculline (1–2 mg/kg). We chose these concen-
trations of bicuculline because they are below those
reported (6–8 mg/kg) to increase anxiety-like behavior
in wild-type mice (28) and are just below the ED50 (2.28
mg/kg) for inducing convulsions in mice (29). Follow-
ing saline injection, corticosterone levels were higher in
wild-type mice compared with PKCε-null mice (Figure
5a). Bicuculline (1–2 mg/kg) elevated corticosterone in
PKCε-null mice to levels observed in wild-type mice,
but as expected had little effect on levels in wild-type
mice (Figure 5a). No mice suffered convulsions at these
concentrations of bicuculline.
If the reduction in corticosterone levels in PKCε-null
mice is related to neurosteroid hypersensitivity, we pre-
dicted that injection of allopregnanolone would reduce
The Journal of Clinical Investigation | October 2002 | Volume 110 | Number 7 1007
Figure 4
Responses to neurosteroids in PKCε-null mice. (a) Muscimol-stimulated 36Cl uptake in the presence of 1 nM allopregnanolone (n = 11 of
each genotype) or 1 µM pregnanolone (n = 4 of each genotype) was greater in tissue from hybrid PKCε-null compared with tissue from hybrid
wild-type mice (two-tailed t tests). (b) Microsacs from frontal cortex of hybrid PKCε-null mice (open circles) show greater muscimol-stim-
ulated 36Cl uptake in the presence of alphaxalone compared with microsacs from hybrid wild-type mice (filled circles). Nonlinear regression
analysis revealed an increased maximal response to alphaxalone in PKCε-null mice (409.4 ± 26.5%; n = 4–8) compared with wild-type mice
(247.1 ± 26.9%, P = 0.005; n = 4–6), without a difference in log ED50 values (–6.86 ± 0.14 in PKCε-null and –6.62 ± 0.20 in wild-type mice;
P = 0.826). (c) The duration of the pregnanolone-induced loss of the righting reflex (LORR) was greater (P = 0.008; two-tailed unpaired
t test) in hybrid male PKCε-null mice (n = 9) compared with wild-type male littermates (n = 8). (d) Total brain levels of alphaxalone were sim-
ilar in hybrid wild-type (n = 8) and PKCε-null (n = 9) mice.
Figure 5
GABAA receptor regulation of corticosterone in PKCε-null mice. (a) Corticosterone levels measured 30 minutes after injection of saline or bicu-
culline in hybrid male PKCε-null (open circles; n = 3–7) and wild-type mice (filled circles; n = 4–6). Two-way ANOVA revealed an effect of geno-
type (F1,25 = 16.11, P < 0.001) and concentration (F2,25 = 7.32, P = 0.003) and a significant interaction between these factors (F2,25 = 3.979, 
P = 0.032). *P < 0.05 compared with saline-treated wild-type mice and with bicuculline-treated PKCε-null mice (Tukey’s test). (b) Corticos-
terone levels in hybrid male PKCε-null (open circles; n = 6–12) and wild-type mice (filled circles; n = 6–10) after intraperitoneal injection of
saline or allopregnanolone followed by 10 minutes of restraint. Two-way ANOVA revealed an effect of genotype (F1,41 = 4.96, P = 0.032) and
concentration (F2,41 = 5.85, P = 0.006) and a significant interaction between these two factors (F2,41 = 3.53, P = 0.039). *P < 0.05 compared
with saline-treated PKCε-null mice and allopregnanolone-treated wild-type mice (Tukey’s test). (c) PKCε-like immunoreactivity in the PVN of
wild-type (PKCε+/+) and PKCε-null (PKCε–/–) mice. Bar, 100 µm.
corticosterone levels, but this effect would be dimin-
ished in PKCε-null mice since their GABAA receptors
would already be more activated by endogenous allo-
pregnanolone than receptors in wild-type mice. We
found that 3–5 mg/kg allopregnanolone administered
before restraint stress reduced plasma corticosterone in
wild-type mice, whereas in PKCε-null mice it had no
effect (Figure 5b). In vitro, allopregnanolone suppress-
es CRF release from hypothalamic explants (30). There-
fore, we investigated whether PKCε is expressed in the
mouse PVN. Immunohistochemical analysis revealed
PKCε-like immunoreactivity in the PVN of wild-type
but not of PKCε-null mice (Figure 5c), consistent with
a role for PKCε in regulating neurosteroid sensitivity of
the HPA axis at the level of the hypothalamus.
If decreased anxiety-like behavior in PKCε-null mice
also results from enhanced activity of GABAA recep-
tors, then we predicted that treatment with a GABAA
receptor antagonist would be anxiogenic in these
mice at a concentration that would have little effect
on anxiety-related behavior in wild-type mice. Using
the elevated plus maze, we found that pretreatment
with 1.5 mg/kg of bicuculline 20 minutes before test-
ing decreased the percentage of time spent in the open
arms and the percentage of open-arm entries in PKCε-
null mice, but not in wild-type mice (Figure 6, a and
b). The number of closed-arm entries was not altered
by bicuculline (Figure 6c).
Discussion
In this study we found that absence of PKCε is associ-
ated with reduced anxiety-like behaviors and decreased
levels of stress hormones in mice. Reduced anxiety-like
behavior was present in hybrid as well as inbred PKCε-
null mice, indicating that despite differences in genetic
background, we could still detect an effect of the PKCε-
null mutation. This was associated with increased sen-
sitivity of GABAA receptors to neurosteroids. Further-
more, treatment with the GABAA receptor antagonist
bicuculline restored levels of stress hormones and anx-
iety-like behavior in PKCε-null mice to wild-type levels.
These results suggest that increased GABAA receptor
sensitivity to endogenous positive neurosteroid modu-
lators contributes to reduced anxiety-like behavior and
stress hormone responses in PKCε-null mice. These
findings also suggest that inhibitors of PKCε might
prove useful as anxiolytic drugs.
Although primary pituitary or adrenal insufficien-
cy reduces ACTH and corticosterone levels, our results
indicate that neither accounts for reduced levels of
stress hormones in PKCε-null mice. For example, we
found that restraint increased corticosterone levels
threefold in wild-type and sixfold in PKCε-null mice.
One hour later, levels still appeared elevated about
2.2-fold in both genotypes, although this was not sta-
tistically significant in PKCε-null mice. This suggests
that HPA axis function is intact but is consistently
downregulated across basal and stress-related condi-
tions in PKCε-null mice. This is supported by the
findings that exogenous CRF evoked similar levels of
ACTH and corticosterone in wild-type and PKCε-null
mice and that adrenal weight was similar in both
genotypes. That corticosterone levels were different
after saline injection despite similar levels of ACTH is
consistent with secondary adrenal insufficiency in
PKCε-null mice due to decreased basal stimulation of
the HPA axis. Reduced levels of stress hormones in
PKCε-null mice are also not due to impaired PVN
function because treatment with metyrapone to
remove glucocorticoid-mediated feedback inhibition
of the PVN evoked similar elevated levels of ACTH
and corticosterone in wild-type and PKCε-null litter-
mates. Taken together, these findings indicate that a
primary defect in HPA axis function does not account
for reduced basal and stress-induced levels of corti-
costerone in PKCε-null mice.
Reduced levels of stress hormones in these mice
could also result from suppression of the HPA axis
through enhanced activation of GABAA receptors on
PVN neurons by GABA released from neurons pro-
jecting to the hypothalamus from other brain regions
(27). In support of this mechanism, we found that
treatment with bicuculline restored wild-type levels of
corticosterone and anxiety-like behavior in PKCε-null
mice, suggesting that reduced levels of stress hor-
mones and anxiety-like behavior in these mice are con-
sequences of enhanced GABAA receptor activity. The
fact that allopregnanolone lowered corticosterone lev-
els in wild-type mice, but not in PKCε-null mice,
strongly suggests that enhanced neurosteroid activa-
tion of GABAA receptors is a major factor reducing
stress hormone levels in PKCε-null mice.
One limitation of our studies is that they were con-
ducted using conventional knockout mice, so it is possi-
ble that the phenotypes observed are due to a develop-
mental change rather than absence of PKCε in adulthood.
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Figure 6
Bicuculline increases anxiety-like behavior in PKCε-null mice. Data are
from 25 wild-type and 23 PKCε-null mice treated with saline and 20
wild-type and 19 PKCε-null mice treated with bicuculline. Two-factor
ANOVA revealed main effects of treatment (F1,84 = 4.2, P = 0.043) on
the percentage of total entries into the open arms (a) and genotype
(F1,84 = 4.4, P = 0.039) on the percentage of time spent in the open
arms (b). There were no significant effects of either factor on the
number of closed-arm entries (c). *P < 0.05 compared with saline-
treated wild-type mice, and P < 0.05 compared with saline-treated
PKCε-null mice (Tukey’s test).
However, we demonstrated previously that exposing
GABAA receptors from wild-type mice to the selective
PKCε inhibitor peptide, εV1-2, produces allosteric super-
sensitivity (20). This indicates that increased GABAA
receptor sensitivity to allosteric modulators in PKCε-null
mice results from absence of PKCε function in adult
neurons and is not likely a consequence of altered nerv-
ous system development. Since our findings here
demonstrate that enhanced GABAA receptor function is
critical for reduced anxiety-like behavior and stress hor-
mone responses in PKCε-null mice, we think it is likely
that these phenotypes also result from absence of PKCε
function in the adult brain, rather than from altered
development. However, proof of this will require studies
in which PKCε is eliminated or restored by an inducible
system in adult mice.
Our finding that absence of PKCε increases the max-
imal response to alphaxalone suggests that PKCε regu-
lates the number of neurosteroid-binding sites available
on GABAA receptors or increases the coupling of sites to
modulation of channel function. We think it more like-
ly to involve coupling of allosteric sites rather than an
increase in receptor density because absence of PKCε
does not affect behavioral or biochemical responses to
direct agonists or alter the binding of the benzodi-
azepine antagonist Ro 15-1788 to brain membranes
(20). It is also unlikely to involve a change in receptor
subunit composition because we found previously that
treating microsacs from wild-type mice for 15 minutes
with a PKCε inhibitor was sufficient to enhance the
GABAA receptor response to flunitrazepam (20). In
addition, transgenic expression of a fragment of PKCε
that inhibits its function (31) also enhanced the GABAA
receptor response to benzodiazepines in cells that
express only α1, β1, and γ2 subunits (T. McMahon and
R. Messing, unpublished observations).
PKC has been implicated in regulating the response
of GABAA receptors to direct agonists. Phorbol esters
(32, 33) or an active catalytic fragment of PKC (PKM)
(34) alter receptor activation by GABA or muscimol,
and functional studies using site-directed mutagenesis
have determined that this modulation is mediated by
phosphorylation of specific serine residues on β1, β2,
and, γ2 subunits (32–34). It is unlikely that these sites
are involved in the effect of PKCε because we found
that activation of GABAA receptors by the direct ago-
nist muscimol was similar in tissue from wild-type and
PKCε-null mice (20). PKCε may phosphorylate other
sites on GABAA receptor subunits or another protein
that modulates receptor responses to allosteric activa-
tors. Identification of the PKCε substrates involved
should provide clues to the mechanism by which PKCε
regulates GABAA receptor function.
Absence of another PKC isozyme, PKCγ, is associated
with reduced anxiety-like behavior in mice (11). How-
ever, absence of PKCγ is not likely to reduce anxiety
through an effect on GABAA receptors because loss of
PKCγ selectively reduces GABAA receptor responses to
ethanol but does not affect responses to direct agonists
or other allosteric drugs (35). PKCγ has been proposed
instead to modulate anxiety through serotonergic
pathways (11). Further work is needed to determine
whether PKCε also modulates serotonergic systems
that control anxiety and hormonal responses to stress.
Acknowledgments
We thank S. Taylor and J. Connolly for technical sup-
port and P. Janak for helpful discussions. This work
was supported by funds provided by the State of Cali-
fornia for medical research on alcohol and substance
abuse through the University of California at San Fran-
cisco and by NIH grants AA-09981 to C.W. Hodge, AG-
20079 to J. Raber, and AA-08117 to R.O. Messing.
1. Kessler, R.C., et al. 1994. Lifetime and 12-month prevalence of DSM-III-R
psychiatric disorders in the United States. Results from the National
Comorbidity Survey. Arch. Gen. Psychiatry. 51:8–19.
2. Deckert, J., et al. 1999. Excess of high activity monoamine oxidase A
gene promoter alleles in female patients with panic disorder. Hum. Mol.
Genet. 8:621–624.
3. Deckert, J., et al. 1998. Systematic mutation screening and association
study of the A1 and A2a adenosine receptor genes in panic disorder sug-
gest a contribution of the A2a gene to the development of disease. Mol.
Psychiatry. 3:81–85.
4. Kennedy, J.L., et al. 1999. Investigation of cholecystokinin system genes
in panic disorder. Mol. Psychiatry. 4:284–285.
5. Wang, Z., Valdes, J., Noyes, R., Zoega, T., and Crowe, R.R. 1998. Possible
association of a cholecystokinin promotor polymorphism (CCK-36CT)
with panic disorder. Am. J. Med. Genet. 81:228–234.
6. Turri, M.G., Datta, S.R., DeFries, J., Henderson, N.D., and Flint, J. 2001.
QTL analysis identifies multiple behavioral dimensions in ethological
tests of anxiety in laboratory mice. Curr. Biol. 11:725–734.
7. Smith, G.W., et al. 1998. Corticotropin releasing factor receptor 1-defi-
cient mice display decreased anxiety, impaired stress response, and aber-
rant neuroendocrine development. Neuron. 20:1093–1102.
8. Timpl, P., et al. 1998. Impaired stress response and reduced anxiety in
mice lacking a functional corticotropin-releasing hormone receptor 1.
Nat. Genet. 19:162–166.
9. Tronche, F., et al. 1999. Disruption of the glucocorticoid receptor gene
in the nervous system results in reduced anxiety. Nat. Genet. 23:99–103.
10. Chen, C., Rainnie, D.G., Greene, R.W., and Tonegawa, S. 1994. Abnor-
mal fear response and aggressive behavior in mutant mice deficient for
alpha-calcium-calmodulin kinase II. Science. 266:291–294.
11. Bowers, B.J., Collins, A.C., Tritto, T., and Wehner, J.M. 2000. Mice lack-
ing PKC gamma exhibit decreased anxiety. Behav. Genet. 30:111–121.
12. Kash, S.F., Tecott, L.H., Hodge, C., and Baekkeskov, S. 1999. Increased
anxiety and altered responses to anxiolytics in mice deficient in the 65-
kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA.
96:1698–1703.
13. Crestani, F., et al. 1999. Decreased GABAA-receptor clustering results
in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2:833–839.
14. Bale, T.L., et al. 2000. Mice deficient for corticotropin-releasing hor-
mone receptor-2 display anxiety-like behaviour and are hypersensitive
to stress. Nat. Genet. 24:410–414.
15. Kishimoto, T., et al. 2000. Deletion of crhr2 reveals an anxiolytic role
for corticotropin-releasing hormone receptor-2. Nat. Genet. 24:415–419.
16. Heisler, L.K., et al. 1998. Elevated anxiety and antidepressant-like
responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad.
Sci. USA. 95:15049–15054.
17. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T., and Toth, M. 1998.
Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl.
Acad. Sci. USA. 95:10734–10739.
18. Ramboz, S., et al. 1998. Serotonin receptor 1A knockout: an animal
model of anxiety-related disorder. Proc. Natl. Acad. Sci. USA.
95:14476–14481.
19. Salzman, C., Miyawaki, E.K., le Bars, P., and Kerrihard, T.N. 1993. Neu-
robiologic basis of anxiety and its treatment. Harv. Rev. Psychiatry.
1:197–206.
20. Hodge, C.W., et al. 1999. Supersensitivity to allosteric GABAA receptor
modulators and alcohol in mice lacking PKCε. Nat. Neurosci.
2:997–1002.
21. Khasar, S.G., et al. 1999. A novel nociceptor signaling pathway revealed
in protein kinase C ε mutant mice. Neuron. 24:253–260.
22. Olive, M.F., Mehmert, K.K., Messing, R.O., and Hodge, C.W. 2000.
Reduced operant ethanol self-administration and in vivo mesolimbic
The Journal of Clinical Investigation | October 2002 | Volume 110 | Number 7 1009
dopamine responses to ethanol in PKCε-deficient mice. Eur. J. Neurosci.
12:4131–4140.
23. VanDoren, M.J., et al. 2000. Neuroactive steroid 3alpha-hydroxy-5alpha-
pregnan-20-one modulates electrophysiological and behavioral actions
of ethanol. J. Neurosci. 20:1982–1989.
24. Kiley, S.C., and Parker, P.J. 1995. Differential localization of protein
kinase C isozymes in U937 cells: evidence for distinct isozyme functions
during monocyte differentiation. J. Cell Sci. 108:1003–1016.
25. Crawley, J.N. 2000. What’s wrong with my mouse? Wiley-Liss. New York,
New York, USA. 329 pp.
26. Paul, S.M., and Purdy, R.H. 1992. Neuroactive steroids. FASEB J.
6:2311–2322.
27. Herman, J.P., and Cullinan, W.E. 1997. Neurocircuitry of stress: central
control of the hypothalamo-pituitary-adrenocortical axis. Trends Neu-
rosci. 20:78–84.
28. Dalvi, A., and Rodgers, R.J. 1996. GABAergic influences on plus-maze
behaviour in mice. Psychopharmacology (Berl). 128:380–397.
29. Yajima, Y., et al. 2000. Effects of differential modulation of mu-, delta-
and kappa-opioid systems on bicuculline-induced convulsions in the
mouse. Brain Res. 862:120–126.
30. Patchev, V.K., Shoaib, M., Holsboer, F., and Almeida, O.F.X. 1994. The
neurosteroid tetrahydroprogesterone counteracts corticotropin-releas-
ing hormone-induced anxiety and alters the release and gene expression
of corticotropin-releasing hormone in the rat hypothalamus. Neuro-
science. 62:265–271.
31. Hundle, B., et al. 1997. An inhibitory fragment derived from protein
kinase Cε prevents enhancement of nerve growth factor responses by
ethanol and phorbol esters. J. Biol. Chem. 272:15028–15035.
32. Kellenberger, S., Malherbe, P., and Sigel, E. 1992. Function of the
α1β2γ2S γ−aminobutyric acid type A receptor is modulated by protein
kinase C via multiple phosphorylation sites. J. Biol. Chem.
267:25660–25663.
33. Krishek, B.J., et al. 1994. Regulation of GABAA receptor function by pro-
tein kinase C phosphorylation. Neuron. 12:1081–1095.
34. Lin, Y.F., et al. 1996. Enhancement of recombinant alpha 1 beta 1
gamma 2L gamma-aminobutyric acid A receptor whole-cell currents by
protein kinase C is mediated through phosphorylation of both beta 1
and gamma 2L subunits. Mol. Pharmacol. 50:185–195.
35. Harris, R.A., McQuilkin, S.J., Paylor, R., Tonegawa, S., and Wehner, J.M.
1995. Mutant mice lacking the γ isoform of protein kinase C show
decreased behavioral actions of ethanol and altered function of 
γ-aminobutyrate type A receptors. Proc. Natl. Acad. Sci. USA. 92:3658–3662.
1010 The Journal of Clinical Investigation | October 2002 | Volume 110 | Number 7
